BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 16781866)

  • 21. Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma.
    Mattioli M; Agnelli L; Fabris S; Baldini L; Morabito F; Bicciato S; Verdelli D; Intini D; Nobili L; Cro L; Pruneri G; Callea V; Stelitano C; Maiolo AT; Lombardi L; Neri A
    Oncogene; 2005 Apr; 24(15):2461-73. PubMed ID: 15735737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligonucleotide-based array CGH as a diagnostic tool in multiple myeloma patients.
    Smetana J; Fröhlich J; Vranová V; Mikulásová A; Kuglik P; Hájek R
    Klin Onkol; 2011; 24 Suppl():S43-8. PubMed ID: 21923064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].
    Liu SY; Huang JW; Zhang J; Du HP; Jiang H; Li JY; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):685-8. PubMed ID: 18067084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletions.
    Chang H; Sloan S; Li D; Keith Stewart A
    Br J Haematol; 2004 Nov; 127(3):280-4. PubMed ID: 15491286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression profiling and multiple myeloma.
    Shaughnessy J; Zhan F; Barlogie B; Stewart AK
    Best Pract Res Clin Haematol; 2005; 18(4):537-52. PubMed ID: 16026736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.
    Chng WJ; Santana-Dávila R; Van Wier SA; Ahmann GJ; Jalal SM; Bergsagel PL; Chesi M; Trendle MC; Jacobus S; Blood E; Oken MM; Henderson K; Kyle RA; Gertz MA; Lacy MQ; Dispenzieri A; Greipp PR; Fonseca R
    Leukemia; 2006 May; 20(5):807-13. PubMed ID: 16511510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease.
    Lombardi L; Poretti G; Mattioli M; Fabris S; Agnelli L; Bicciato S; Kwee I; Rinaldi A; Ronchetti D; Verdelli D; Lambertenghi-Deliliers G; Bertoni F; Neri A
    Genes Chromosomes Cancer; 2007 Mar; 46(3):226-38. PubMed ID: 17171682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype.
    Rio-Machin A; Ferreira BI; Henry T; Gómez-López G; Agirre X; Alvarez S; Rodriguez-Perales S; Prosper F; Calasanz MJ; Martínez J; Fonseca R; Cigudosa JC
    Leukemia; 2013 Apr; 27(4):925-31. PubMed ID: 23174883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myeloma.
    Chng WJ; Ketterling RP; Fonseca R
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1111-20. PubMed ID: 16955468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytogenetic and molecular aberrations of multiple myeloma patients: a single-center study in Singapore.
    Lim AS; Lim TH; See KH; Ng YJ; Tan YM; Choo NS; Lim SX; Yee Y; Lau LC; Tien SL; Sathish K; Tan DC
    Chin Med J (Engl); 2013; 126(10):1872-7. PubMed ID: 23673102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
    Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
    Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromosome 1 abnormalities in multiple myeloma.
    Marzin Y; Jamet D; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
    Anticancer Res; 2006; 26(2A):953-9. PubMed ID: 16619492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytogenetic characteristics of patients with multiple myeloma in China: analysis of 100 case].
    Deng SH; Xu Y; Wang YF; Mai YJ; Liu XP; Zhao YZ; Zou DH; Wang Y; Qiu LG
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1685-8. PubMed ID: 17825148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissecting karyotypic patterns in non-hyperdiploid multiple myeloma: an overview on the karyotypic evolution.
    Jimenez-Zepeda VH; Braggio E; Fonseca R
    Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):552-8. PubMed ID: 23856591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular and molecular genetic features of myeloma and related disorders.
    Durie BG
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):463-77. PubMed ID: 1582985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of immunoglobulin light chain gene aberrations as revealed by FISH in multiple myeloma and MGUS.
    Türkmen S; Binder A; Gerlach A; Niehage S; Theodora Melissari M; Inandiklioglu N; Dörken B; Burmeister T
    Genes Chromosomes Cancer; 2014 Aug; 53(8):650-6. PubMed ID: 24729354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytogenetic Abnormalities in Multiple Myeloma Patients at a Tertiary Healthcare Center in India.
    Govindasamy P; Pandurangan P; Tarigopula A; Mani R; R Samuel C
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):235-241. PubMed ID: 30678438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosomal translocations t(4;14), t(11;14) and proliferation rate stratify patients with mature plasma cell myelomas into groups with different survival probabilities: a molecular epidemiologic study on tissue microarrays.
    Tinguely M; Jenni B; Reineke T; Korol D; Kofler A; Rousson V; Dommann-Scherrer C; Maurer R; Moch H; Probst-Hensch NM
    Am J Surg Pathol; 2007 May; 31(5):690-6. PubMed ID: 17460451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular genetic methods for the prognostic criteria in multiple myeloma].
    Mikala G; Jákó J; Vályi-Nagy I
    Orv Hetil; 2005 Aug; 146(32):1673-82. PubMed ID: 16149245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics.
    Bink K; Haralambieva E; Kremer M; Ott G; Beham-Schmid C; de Leval L; Peh SC; Laeng HR; Jütting U; Hutzler P; Quintanilla-Martinez L; Fend F
    Haematologica; 2008 Apr; 93(4):623-6. PubMed ID: 18326524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.